• Thu
    22
    Nov
    2018

    Read our article about this new EU Funding here 

    Call text available here

     

  • Wed
    21
    Nov
    2018
    Thu
    22
    Nov
    2018
    Brussels, Belgium

    The 4th Conference on European Reference Networks, "ERNs in action", will take place in Brussels on November 21-22, 2018. Further details TBA.

  • Wed
    21
    Nov
    2018
    Thu
    22
    Nov
    2018
    Brussels, Belgium

    The 4th Conference of the European Reference Networks (ERNs) entitled "ERNs in action" will take place in Brussels, Belgium from November 21-22, 2018.

    Atleast 10 representatives from VASCERN will be in attendance.

    Further details TBA.

  • Tue
    06
    Nov
    2018
    Thu
    08
    Nov
    2018
    Barcelona, Spain

    Europe’s largest Orphan Drug Congress will be back for an 8th session from November 6-8, 2018 in Barcelona Spain. This congress allows the rare disease community a chance to discover the latest developments and technologies in the orphan drugs industry.

    All information and registration on the event page here

  • Fri
    26
    Oct
    2018
    8:30AM-18:35PMBudapest, Hungary

    The first Central-Eastern European Marfan Symposium, organised by our HCP Member, Prof. Zoltán Szabolcs, MD; and Dr Kálmán Benke, MD, PhD; Heart and Vascular Center, Semmelweis University, Budapest, will take place on October 26th, 2018 in Budapest, Hungary.

    Prof Guillaume Jondeau, VASCERN Coordinator, will present VASCERN and the HTAD-WG at this event.

    (1) European Reference Network for Vascular Diseases (VASCERN)
    Prof. Guillaume Jondeau, MD; Director, Heart Failure Unit, Cardiology Department, Claude Bichat-Claude Bernard Hospital, Paris Director, Centre de référence sur le syndrome de Marfan et apparentés

    Prof Julie De Backer, VASCERN HTAD-WG Chair, will be also in attendance and present:

    (8) Marfan cardiomyopathy
    Prof. Julie De Backer, MD; Centrum Medische Genetica, Gent

    Prof. Jolien Roos-Hesselink, from our HCP Member Erasmus MC, Rotterdam, HTAD-WG Member, will also be presenting:

    (11) Pregnancy in Marfan syndrome
    Prof. Jolien Roos-Hesselink, MD; Erasmus MC, Rotterdam

    To see theprogram, click here

    All information and registration here

  • Thu
    11
    Oct
    2018
    Fri
    12
    Oct
    2018
    Paris, France

    VASCERN Days 2018 (2 days annual seminar) will take place on October 11-12, 2018 in Paris, France.

     

  • Wed
    26
    Sep
    2018
    Sat
    29
    Sep
    2018
    Ghent, Belgium

    The International Symposium of the Ehlers-Danlos Syndromes will take place in Ghent, Belgium, from the 26-29 of September 2018.

    Members of our Medium-Sized Artery Working Group (MSA-WG), including Dr. Leema Robert (Chair of MSA-WG), will be in attendance.

    For more information, click here

    To register for this event, click here

  • Wed
    12
    Sep
    2018
    Fri
    14
    Sep
    2018
    Liège, Belgium

    The 6th edition of the International Meeting on Aortic Diseases will be held from September 12-14, 2018 in Liège, Belgium.

    "The main goal of The International Meeting on Aortic Diseases (IMAD) is to gather all cardiovascular clinicians and scientists to share their experiences on basic research, genetic aspects of aortic aneurysms, aortic dissections, aortitis, aortic graft infection and their treatment as well as on the new pathophysiological concepts in bicuspid aortic valve, TAVI indications and surgical treatment of aortic valve diseases and also, to provide information about the latest innovations in spinal cord protection."

    Speakers at this event include Prof Julie De Backer (our HTAD WG Chair and MSA WG member) and Prof Bart Loeys (member of the HTAD and MSA WGs).

    Register for this exciting event here

    For the full program and all other information click here

  • Mon
    10
    Sep
    2018
    Fri
    14
    Sep
    2018
    Rome, Italy

    The 6th International Summer School Rare Disease & Orphan Drug Registries, including a “Bring Your Own Data – BYOD” to Link Rare Disease Registries session, will take place from September 10-14, 2018, at the Istituto Superiore di Sanità in Rome, Italy.

    The International Summer school intends: i) to promote the establishment of Findable, Accessible, Interoperable, Reusable (FAIR) registries in compliance with IRDiRC and EU Recommendations, with particular attention to governance, quality, sustainability and legal issues; ii) to support cooperation among different registry stakeholders and coordination with registries that are developed within European Reference Networks (ERNs) and National Plans in the EU.
    The School will consist of plenary presentations and interactive small-group exercises, according to the Problem-Based Learning methodology.

    The first part (September 10-12, 2018) will provide participants with useful tools and methodologies to plan, establish and manage the registry activities.

    The second part (September 13-14, 2018) will be a hands-on experience (Bring Your Own Data), where the attendees work with FAIR data experts to make their data FAIR and linked to other data that has been made FAIR before.

    The School is open to health professionals, researchers, medical specialists, registry curators, database managers and representatives of patients associations involved in or intend to establish a rare disease registry, including inside European Reference Networks.

    Prof Guillaume Jondeau, VASCERN Coordinator, will represent VASCERN at the first part of this event.

    Register before May 30th, 2018 via the online registration form here

    The provisional agenda for the event can be found here

    For more information click here

     

  • Thu
    06
    Sep
    2018
    Sat
    08
    Sep
    2018
    Helsinki, Finland

    The 7th Nordic Congress of Lymphology will take place in Helsinki, Finland, from September 6-9, 2018.

    Members from both the VASCA-WG (including Chair, Prof Miikka Vikkula) and PPL-WG (including Chair Prof Robert Damstra) will be giving presentations at this event!

    To register for this event click here

    For more information click here

  • Wed
    29
    Aug
    2018
    8:00AM-9:00AM (CET)Videoconference call - Webex
  • Sat
    25
    Aug
    2018
    Wed
    29
    Aug
    2018
    Munich, Germany

    The European Society of Cardiology (ESC) Congress 2018, the world's largest cardiovascular congress, will take place from August 25-29th, 2018 in Munich, Germany.

    For more information click here

    Early Registration Deadline: May 31, 2018.

    Register for this event here

  • Mon
    23
    Jul
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Wed
    18
    Jul
    2018
    16:00PM-17:00PM (CET)Videoconference call - Webex
  • Mon
    16
    Jul
    2018
    17:30PM-18:30PM (CET)Videoconference call - Webex
  • Wed
    11
    Jul
    2018
    Fri
    13
    Jul
    2018
    Warth (Canton Thurgau), Switzerland

    The 6th radiz Rare Diseases Summer School will take place in the Kartause Ittingen, Warth (Canton Thurgau), Switzerland, from July 11th to July 13th 2018. It is organised by radiz, a clinical research priority program of the University of Zurich with collaborations between the Children's Hospital Zurich, the University of Zurich, and the UniversityHospital Zurich.

    Lectures by national and international rare disease experts, workshops and poster presentations by participants will all take place during this 3 day event!

    Application deadline: April 9th 2018.

    See preliminary programme here

    For more information click here

  • Wed
    11
    Jul
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Wed
    11
    Jul
    2018
    8:00AM-9:00AM (CET)Videoconference call - Webex
  • Tue
    10
    Jul
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Wed
    04
    Jul
    2018
    18:00PM-19:00PM (CET)Videoconference call - Webex

    The 5th VASCERN Council Meeting will take place on July 4th, 2018 at 6PM.

  • Mon
    02
    Jul
    2018
    Tue
    03
    Jul
    2018
    London, UK

    The International Congress on Advanced Treatments in Rare Diseases (RARE2018) will take place from July 2-3, 2018 in London, UK. This congress will address the challenges of developing rare disease treatments as well present the latest in rare disease therapies.

    Early bird registration, until March 14, 2018,  here

    For full programme, click here

    For further information click here

  • Thu
    28
    Jun
    2018
    Fri
    29
    Jun
    2018
    Rome, Italy

    The International Conference on Vascular Anomalies organized by La Società Italiana per lo Studio delle Anomalie Vascolari (SISAV) will take place from June 28-29, 2018 in Rome, Italy.

    Members of the VASCA-WG will be giving presentations at this event, including Prof Miikka Vikkula (Chair), Prof Laurence Boon, Dr May El Hachem, and Dr Andrea Diociaiuti.

    Link to the program here

  • Tue
    26
    Jun
    2018
    Brussels, Belgium

    The representatives of the Ministry of Health will meet at the ERN Board of Member States meeting.

  • Mon
    25
    Jun
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Mon
    25
    Jun
    2018
    8:45AM-17:00PMBrussels, Belgium

    The 5th meeting of the ERN Coordinators Group (ERN-CG) will take place on June 25th, 2018 in Brussels, Belgium.

    It will be preceeded by the internal coordinator's meeting.

  • Fri
    22
    Jun
    2018
    8:30AM-17:00PMEspace Grenelle, 84 rue de Grenelle, Paris 7ème

    The Annual FAVA-Multi (The French Network for Rare Vascular Diseases) Day will take place on June 22, 2018 in Paris, France. Prof Guillaume Jondeau (Coordinator of both FAVA-Multi and VASCERN) will be at this event.

    Marine Hurard, VASCERN Project Manager, will present VASCERN's actions to date.

    The program of the event, in French, can be found here

     

  • Wed
    20
    Jun
    2018
    16:00PM-17:00PM (CET)Videoconference call - Webex
  • Mon
    18
    Jun
    2018
    17:30PM-18:30PM (CET)Videoconference call - Webex
  • Sat
    16
    Jun
    2018
    Tue
    19
    Jun
    2018
    Milan, Italy

    The latest advances in human genetics will be explored at the the 51st European Human Genetics Conference in Milan, Italy from June 16-19, 2018. Participants from all over the world will be in attendance and VASCERN members, Prof Laurence Boon (VASCA WG) and Prof Miikka Vikkula (Chair of VASCA WG) will be speakers at this exciting event with presentations entitled "Etiology of vascular malformations: A question of place and timing" and "Clinical management of vascular malformations"

    Deadline to submit an abstract: Friday, March 9, 2018

    Early bird deadline: Friday, April 6, 2018

    Link to programme here

    For further information visit the event website here

  • Wed
    13
    Jun
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Tue
    12
    Jun
    2018
    10:00AM-11:00AM (CET)Videoconference call - Webex
  • Mon
    11
    Jun
    2018
    Fri
    15
    Jun
    2018
    Barcelona, Spain

    The EURORDIS summer school is taking place in Barcelona from the 11 - 15 June 2018. This year, the summer school will focus on educating patients and researchers on the regulatory process of orphan medicinal products in Europe in order to strengthen their advocacy skills. The last day to register for the English edition is November 30th, 2017 and the last day to register for the Spanish edition is December 15th, 2017.

    All information here

  • Fri
    08
    Jun
    2018
    9:00AM-1:00PM (CET)Brussels, Belgium

    The second meeting of the Scientific Committee of the 101 Genomes Marfan project (P101GM) will take place on June 8, 2018 in Brussels, Belgium.

    The P101GM is the first pilot project of The 101 Genomes Foundation, a private Foundation that was created in November 2017 by Ludivine Verboogen & Romain Alderweireldt (Chair of the VASCERN Ethics WG and ePAG representative for the Association Belge du Syndrome de Marfan) who are parents of a child with Marfan syndrome. Its aim is to improve the lives of people affected by rare diseases by supporting research and development through the creation of a bioinformatics platform containing genomic and phenotypic cross-data from a cohort of 101 patients.

  • Wed
    06
    Jun
    2018
    Sat
    09
    Jun
    2018
    Rotterdam, The Netherlands

    The 8th International Lymphoedema Framework (ILF) Conference will take place from the 6th-9th of June, 2018 in Rotterdam, the Netherlands. This conference, hosted by the ILF and the Dutch Lymphoedema Framework (NLNet) will be a great opportunity for healthcare professionals, researchers, patients, and industry to discuss the latest advances in the treatment and care of lymphoedema and to raise awareness in order to make it a priority on all national health agendas.

    There will also be a Children's Day on June 9th, where children can participate in a variety of workshops all centered around the theme ‘Children and edema: a dynamic duo’.

    Register here

    For more information, click here!

  • Wed
    06
    Jun
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex

    The VASCERN Patient Registry WG meeting #6 will take place place on June 6, 2018 at 5 pm.

  • Thu
    31
    May
    2018
    17:30 PM - 18:30 PM (CET)Videoconference call - Webex
  • Wed
    30
    May
    2018
    Fri
    01
    Jun
    2018
    Amsterdam, The Netherlands

    The 22nd ISSVA (International Society for the Study of Vascular Anomalies) International Workshop will be held in Amsterdam, Netherlands from May 29-June 1st, 2018. This biannual meeting will be co-chaired by Prof Leo Schultze Kool (co-chair of the VASCA WG and chair of the Patient Registry WG) and will be attended by specialists from expert centres all around the world.

    All of the HCP members of the VASCA WG will be represented and a large number of them will equally be speaking at the event or presenting posters. Our VASCA-WG will use this opportunity to assemble for a face-to-face meeting on Monday May 28th.

    This year, for the first time, patient organisations will be actively involved and there will be a Patient Organisations meeting that will take place on the afternoon of Tuesday May 29th, 2018.

    This biannual meeting, which is attended by a wide array of specialists including intervention radiologists, dermatologists, plastic surgeons, ENT surgeons, pediatricians, pediatric surgeons, oncologists and pathologists, presents the latest developments in this fast moving area.

    Watch the promotional video here

    Early bird registration deadline: 16 March 2018

    Discounted registration deadline: 1 May 2018

    All information and registration on the event page here

  • Tue
    29
    May
    2018
    Wed
    30
    May
    2018
    London, UK

    An RD-Action workshop, co-organised with the European Medicines Agency (EMA) and with DG Sante, will take place in London from May 29th-30th, 2018.

    This event hopes to showcase the ERNs to the EMA, to explore how ERNs can add value to clinical trials/studies, and to define some concrete steps towards a more strategic engagement with the EMA, in particular, in future.

    Prof Claire Shovlin (Chair of our HHT-WG) will represent VASCERN at this event.

    More information TBA.

  • Tue
    29
    May
    2018
    London, UK

    The VASCERN HHT-WG will have a face-to-face meeting in London, UK on May 29th, 2018. Further details on this meeting TBA.

  • Tue
    29
    May
    2018
    Brussels, Belgium

    The VASCERN HTAD-WG will hold a face-to-face meeting in Brussels, Belgium on May 29th, 2018. Further details on this meeting TBA.

  • Mon
    28
    May
    2018
    Amsterdam, The Netherlands

    Our VASCA-WG will assemble for a face-to-face meeting on Monday May 28th in Amsterdam, The Netherlands.

    This meeting will be held before the ISSVA 22nd International Workshop, that runs from May 30th-June 1st, 2018. More details here.

  • Wed
    23
    May
    2018
    London, UK

    The VASCERN MSA WG will hold a face-to-face meeting on May 23rd, 2018 in the framework of the Pan London aortopathy meeting at Guy's Hospital in
    London, UK. Further details TBA.

  • Wed
    23
    May
    2018
    13:00 - 17:20 BSTLondon, UK

    The Pan-London Aortopathy meeting with Focus on Pregnancy will take place in London on the afternoon of May 23rd, 2018. This meeting will follow the MSA-WG face-to-face meeting in the morning.

    Dr. Leema Roberts and Dr. Yaso Emmanuel (Chair and member of the MSA-WG) will give a presentation entitled "Introduction to the European Reference Network (ERN) for Rare Vascular diseases" and a discussion period will allow participants to give their feedback on what topics they think should be covered by the soon to be created 'pills of knowledge' by the MSA-WG.

    Read the full programme here

     

  • Tue
    22
    May
    2018
    10:00AM-11:00AM (CET)Videoconference call - Webex
  • Wed
    16
    May
    2018
    16:00PM-17:00PMVideoconference call - Webex
  • Tue
    15
    May
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Thu
    10
    May
    2018
    Sat
    12
    May
    2018
    Vienna, Austria

    ECRD – the European Conference on Rare Diseases & Orphan Products is the largest multi-stakeholder gathering in Europe for the rare disease community covering research, development of new treatments, healthcare, social care, public health policies and support at European, national, regional and international levels.

    All information & registration available here

    Deadline to register: 27 April 2018
    Early-bird cut off date: 15 March 2018

    Programme

  • Sun
    06
    May
    2018
    Amsterdam, the Netherlands

    The Marfan Foundation’s First International Patient Symposium on Marfan Syndrome and Related Disorders will be held on May 6th, 2018 in Amsterdam, The Netherlands.

    This event will feature leading medical speakers from several countries, including the US, and will offer both education and support programs that were created to increase a patient's understanding of Marfan and related disorders, answer any questions about diagnosis and treatment, and improve the quality of life of patients with these diseases.

    Topics pertaining to adults, teens, and children with Marfan and related disorders will be covered. The program also includes a Creating Connections Luncheon where patients can spend time networking with people in their area who also have Marfan or a related disorder.

    After the main program there will be time for a meet and greet with the doctors and fellow patients from across Europe.

    To register for this event click here

    For more information on this event click here

     

  • Thu
    03
    May
    2018
    Sat
    05
    May
    2018
    Amsterdam, The Netherlands

    The 10th International Research Symposium on Marfan Syndrome (MFS) and Related Disorders (RD) will take place from the 3rd-5th of May, 2018 in Amsterdam, The Netherlands.

    This symposium brings together the world’s leading experts (including members from the VASCERN HTAD WG) to discuss the most recent and innovative research on MFS and RD. A wide variety of topics will be discussed including sessions on  "Genetic and Environmental Modifiers of MFS and RD Phenotypic Variability" to "Medical and Holistic Treatment Options for Pain in MFS".

    Early bird registration ends on February 1st, 2018! To register for this event, click here

    Find the schedule for the event here

    For further information, click here

     

  • Wed
    02
    May
    2018
    Amsterdam, The Netherlands

    The 2nd Vascular Ehlers Danlos Syndrome (vEDS)Scientific Meeting will take place May 2, 2018 in Amsterdam, the Netherlands. This meeting will bring together some of the brightest minds within the international vEDS community to discuss current needs and concerns, as well as recent advances in their research.

    Several VASCERN MSA-WG members will be present at this event including Dr. Leema Robert (Chair), Prof Xavier Jeunemaître (Co-Chair), Prof Julie De Backer and Dr. Michael Frank.

    More information here

  • Thu
    26
    Apr
    2018
    17:00PM (CET)

    The objective of this action is to support Member states in improving the gathering of information on rare diseases by the implementation of Orphacodes (rare diseases specific codification system).

    For more information click here

    Submission deadline: 26 April 2018 at 17:00 PM (CET)

  • Mon
    23
    Apr
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Sat
    21
    Apr
    2018
    Tue
    24
    Apr
    2018
    Manchester, UK

    The third cardiogenetics training course supported by the European Society of Human Genetics will take place in Manchester, UK (course organizers: Prof Bill Newman, Manchester Centre for Genomic Medicine; Prof Bart Loeys, Clinical Genetics, University of Antwerp; prof Johan Saenen, cardiology, University of Antwerp) from Saturday April 21st to Tuesday April 24th 2018.

    The course is mainly intended for young trainees in genetics and cardiology and consists of lectures, interactive and case-based teaching covering clinical and molecular aspects of cardiogenetic disorders. Speakers at this event include Prof Bart Loeys (VASCERN HTAD and MSA WG member) and Prof Xavier Jeunemaitre (VASCERN MSA-WG Co-Chair).

    For course program, all practical information and to register for the course please go via the ESHG website here

    Ten ESHG scholarschips (covering registration and accommodation) are available for young cardiologists/ clinical geneticists in training from European Countries. Preference will be given to students from countries which are disadvantaged economically. To apply for a scholarship please send after registration a motivation letter to anne.m.burns@manchester.ac.uk.

     

  • Wed
    18
    Apr
    2018

    The European Commision Call for the European Joint Programme Co-fund on Rare Diseases has been published:

    http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-04-2018.html

    The overall objective is to implement a European Joint Programme (EJP) Cofund for Rare Diseases which would create a research and innovation pipeline "from bench to bedside" ensuring rapid translation of research results into clinical applications and uptake in healthcare for the benefit of patients.

    The initiative should follow the policies and contribute to the objectives of the International Rare Diseases Research Consortium (IRDiRC).

  • Wed
    18
    Apr
    2018
    16:00PM-17:00PMVideoconference call - Webex
  • Wed
    18
    Apr
    2018
    17:00PM-18:00PMVideoconference call - Webex
  • Mon
    16
    Apr
    2018
    17:30PM-18:30PM (CET)Videoconference call - Webex
  • Wed
    11
    Apr
    2018
    Fri
    13
    Apr
    2018
  • Tue
    10
    Apr
    2018
    10:00AM-11:00AM (CET)Videoconference call - Webex
  • Tue
    10
    Apr
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Wed
    28
    Mar
    2018
    8:00AM-9:00AM (CET)Videoconference call - Webex
  • Mon
    26
    Mar
    2018
    Thu
    29
    Mar
    2018
    Cambridge, UK

    All information on this conference here

  • Mon
    26
    Mar
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Mon
    19
    Mar
    2018
    17:30 PM - 18:30 PM (CET)Videoconference call - Webex
  • Thu
    15
    Mar
    2018

    The European Research Area Network on Cardiovascular Diseases (ERA-CVD) has announced the Joint Transnational Call 2018 (JTC 2018) entitled “Transnational Cardiovascular Research Projects driven by Early Career Scientists” that opened on January 11th, 2018.

    This call is open to all early career scientists, which is defined as a scientist that has “been awarded his/her first doctoral degree at least 3 years and up to 10 years prior to the pre-proposal deadline of the ERA-CVD JTC 2018”, in the field of cardiovascular diseases. Funding will only be awarded to transnational projects with a minimum three research groups from three different countries (for the list of eligible countries and their corresponding funding organisations, see link below).

    This call aims to foster international collaboration and interchange between early career scientists in order to answer key questions in cardiovascular disease research with innovative and ambitious multidisciplinary research projects.

    Link to call text here

    For all other information: http://www.era-cvd.eu/294.php

    Call opens: January 11, 2018

    Deadline for submission the pre-proposals: March 15, 2018, 17:00 CET

    Deadline for submission the full-proposals: June 15, 2018, 17:00 CET

  • Wed
    14
    Mar
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Tue
    13
    Mar
    2018
    10:00AM-11:00AM (CET)Videoconference call - Webex
  • Thu
    08
    Mar
    2018
    Fri
    09
    Mar
    2018
    Milan, Itlay

    The Joint Research Centre (JRC) of The European Commission will hold its second training workshop on the European RD Registry Infrastructure (ERDRI) Tools on March 8-9th in Milan Italy. This session will deal specifically with the Pseudonymisation Tool and the Search Broker.

    VASCERN will be represented at this event by Prof Leo Schultze Kool, Chair of the Patient Registry WG, along with Dr Susan Marelli and Dr Raffaella Gaetano.

  • Thu
    08
    Mar
    2018
    18:00PM-19:00PM (CET)Videoconference call - Webex

    The VASCERN Patient Registry WG meeting #5 will take place place virtually on March 8, 2018 at 6pm.

  • Wed
    07
    Mar
    2018
    Sat
    10
    Mar
    2018
    Bologna, Italy

    The RE(ACT) CONGRESS, the International Congress on Research of Rare and Orphan Diseases, will take place in Bologna, Itlay from July 7-10, 2018.

    All information about the RE(ACT) CONGRESS & registration available here.

    For a limited time, a special registration rate for the RE(ACT) Congress 2018 is available. The special price is 250 Euros (only payable by credit card and not applicable to private companies). To benefit of the special rate, please register on the registration page and insert the promotional code “HAPPYCRAZYRATE” at the end of the form.

  • Wed
    07
    Mar
    2018
    18PM-19PM (CET)Videoconference call - Webex

    The VASCERN Council meets every 4 months, or more depending on needs. This is the 4th VASCERN Council meeting. The Council is chaired by the Coordinator and Members are the Chairs of our Working Groups.

  • Tue
    06
    Mar
    2018
    10:00AM-16:30PM (CET)Brussels, Belgium
  • Tue
    06
    Mar
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Mon
    05
    Mar
    2018
    Brussels, Belgium

    The 4th ERN Coordinators Group Meeting will take place on March 5th, 2018 in Brussels, Belgium.

  • Wed
    28
    Feb
    2018
    Worldwide

    Rare Disease Day 2018 will take place on February 28th, 2018! This yearly International event aims to to raise awareness for Rare Diseases with the general public and policy-makers and everyone is encouraged to take part!

    There will be numerous events all around the world, including a Rare Disease Day 2018 event in Paris, France organised by the French Rare Disease Networks. The "Rare Disease Village" will take place in Paris under the canopy of the Forum des Halles. Visitors will be able to participate in a wide variety of interactive activities including a central area dedicated to adaptive sports, rare disease quizzes with prizes, a photobooth and various workshops on different themes such as "Dare Diseases and Nutrition" and "Introduction to Rare Disease Research". This event aims to reach out to the general public in order to raise awareness for rare diseases.

    VASCERN will equally be in attendance at this event in order to inform the public about VASCERN and the European Reference Networks (ERNs) in general. We look forward to seeing you  there!

    Link to the event here

    For a list of events near you click here

    All information at https://www.rarediseaseday.org/

    The official 2018 Rare Disease Day video is now available (in 24 languages)! Find it here

     

  • Mon
    26
    Feb
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Mon
    26
    Feb
    2018
    17:30PM-18:30PMVideoconference call - Webex
  • Thu
    22
    Feb
    2018
    Sat
    24
    Feb
    2018
    Brussels, Belgium

    The International Symposium entitled "Revisiting Fibromuscular Dysplasia and Related Vascular Diseases" will take place in Brussels, Belgium from February 22-24, 2018.

    This exciting event will unite the top experts in Fibromuscular Dysplasia (FMD) including the meeting's Co-President, Prof Alexandre Persu, who is an expert in FMD and in charge of the Hypertension Clinic at the Université Catholique de Louvain (Cardiology Department, Cliniques Universitaires Saint-Luc, Brussels), a centre we hope to include in the upcoming expansion of the VASCERN network.

    VASCERN members Prof Bart Loeys, Prof Xavier Jeunemaitre and Prof Miikka Vikkula will also be in attendance!

    To register click here

    Full programme here

    Additional information here

  • Wed
    21
    Feb
    2018
    Brussels, Belgium

    The 26th EURORDIS Round Table of Companies Workshop, entitled "Rare disease therapies: do you get what you incentivise?" will take place on February 21st, 2018 in Brussels, Belgium.

    This workshop will bring together stakeholders interested rare diseases and orphan drug development to discuss the role of incentives in rare disease therapies development,  the shortcomings of the current system and the strategies that the rare disease community can use to fulfill important unmet medical needs.

    See the preliminary Programme here

    For more information, click here

  • Wed
    21
    Feb
    2018
    11 AM-4 PMInstitut Imagine, Paris

    The European Joint Programme on Rare Diseases is currently under elaboration. European Reference Networks are partners of this future new European programm.e for Rare Diseases research. Professor Claire Shovlin and Marine Hurard will be attending for VASCERN at this event.

  • Wed
    21
    Feb
    2018
    16:00PM-17:00PMVideoconference call - Webex
  • Wed
    21
    Feb
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Tue
    13
    Feb
    2018
    10:00AM-11:00AM (CET)Videoconference call - Webex
  • Tue
    13
    Feb
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Fri
    09
    Feb
    2018
    Paris, France

    The 3rd International Congress organized by UNSED, French National Union of Ehlers-Danlos syndromes, will take place in Paris, France on February 9th, 2018. Prof Xavier Jeunemaitre (MSA-WG Co-Chair) will be one of the speakers at this event, where he will give a presentation on the latest news in vascular EDS.

    More information here

     

  • Fri
    09
    Feb
    2018
    8:00AM-9:00AM (CET)Videoconference call - Webex
  • Thu
    08
    Feb
    2018
    Fri
    09
    Feb
    2018
    Baveno, Italy

    The Joint Research Centre of The European Commission will host a training workshop on Rare Disease Registries from February 8-9th, 2018 in Baveno, Italy.

    Prof Leo Schultze Kool (Patient Registry WG Chair) and Dr. Alessia Paglialonga will be attending for VASCERN.

  • Tue
    06
    Feb
    2018

    The launch of the 10th E-Rare-3 Call for Proposals 2018 "Transnational research projects on hypothesis-driven use of multi-omic integrated approaches for discovery of disease causes and/or functional validation in the context of rare diseases" occurred on December 7, 2018.

    This call is aimed at scientists from different countries (see link below for list of 18 countries eligible and their respective funding organisations) wishing to establish a successful international collaboration on a common research project involving a group of rare diseases or a single rare disease. Each consortium submitting a proposal must be composed of atleast 3 eligible research partners from at least 3 different countries.

    Project proposals should highlight the added-value of transnational collaboration, should focus on hypothesis-driven use of multi-omic integrated approaches and should have a strong translational research orientation. The total budget available for this call is 18.54 M€.

    Joint Pre-proposal submission deadline: February 6, 2018 at 5 p.m. CET.

    Joint full proposal deadline (if invited): June 19, 2018 at 5 p.m. CET

    For all information on the call, including the guidelines for applicants and pre-proposal submission form, click here

  • Mon
    05
    Feb
    2018
    Tue
    06
    Feb
    2018
    Paris, France

    The European Joint Programme (EJP) Cofund on Rare Diseases will have its second meeting on the 5-6 of February, 2018 in Paris, France to work on the writing of the application for this instrument that aims to support coordinated national research and innovation programmes. Professor Claire Shovlin (Chair of the HHT-WG) will be in attendance for VASCERN at this event.

     

  • Sun
    04
    Feb
    2018
    Thu
    08
    Feb
    2018
    Melbourne, Autralia

    The 18th UIP World Congress of Phlebology will take place in Melbourne, Australia from February 4-8, 2018. It is the largest international gathering of the phlebology community. Phlebology is a multi-disciplinary field studying disorders of venous origin. Three VASCERN members are keynote invited speakers at this event: Prof Miikka Vikkula (Chair of our VASCA-WG), Prof Laurence Boon (VASCA-WG) and Prof Vaughan Keeley (PPL-WG).

    To register or find more information on this event click here!

  • Mon
    29
    Jan
    2018
    8:00 AM-9:00 AM (CET)Videoconference call - Webex
  • Thu
    25
    Jan
    2018
    16:00PM-18:00PM (CET)Videoconference call - Webex

    The VASCA WG will have their second meeting on the Orphanet classification of Rare Vascular Anomalies.

  • Mon
    22
    Jan
    2018
    Luxembourg

    The Consumers, Health, Agriculture and Food Executive Agency (CHAFEA)'s Worskshop on the Preparation of Final ERN Specific Grant Agreement (SGA) Technical and Financial Reports will be held on Monday January 22nd, 2018 in Luxembourg.

  • Mon
    22
    Jan
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Fri
    19
    Jan
    2018
    Brussels, Belgium

    The first meeting of the Scientific Committee of the 101 Genomes Marfan project (P101GM) will take place on January 19th, 2018 in Brussels, Belgium.

    The P101GM is the first pilot project of The 101 Genomes Foundation, a private Foundation that was created in November 2017 by Ludivine Verboogen & Romain Alderweireldt (Chair of the VASCERN Ethics WG and ePAG representative for the Association Belge du Syndrome de Marfan) who are parents of a child with Marfan syndrome. Its aim is to improve the lives of people affected by rare diseases by supporting research and development through the creation of a bioinformatics platform containing genomic and phenotypic cross-data from a cohort of 101 patients.

    The P101GM, dedicated to patients with Marfan syndrome, will aim to offer scientists a bioinformatics platform containing the genomic and phenotypic data of a starting cohort of 101 patients with Marfan syndrome, in the hopes of better understanding the variability and intensity of clinical manifestations seen in this disease. By using the most innovative technological tools currently available, it is hoped that researchers will be able to identify potential modifier genes (genes that affect the expression of one or more other genes) that may play a role in the severity of cardiovascular, skeletal and ocular manifestations seen in patients with Marfan syndrome, which could ultimately lead to the development of new therapeutic approaches.

    The following participants will be present at this first meeting, organised by Ludivine Verboogen and Romain Alderweireldt: Prof Julie De Backer (Chair of the VASCERN HTAD WG), Prof. Anne De Paepe, Prof. Catherine Boileau (AP-HP, Bichat-Claude Bernard Hospital, Paris, France), Dr. Guillaume Smits, Prof. Bart Loeys (member of HTAD WG) and his collaborator Aline Verstraeten, Prof. Paul Coucke, Dr. Marjolijn Renard, Dr. Michel Verboogen, Me Bruno Fonteyn, Annemie T’Seyen and Julien Wolff.

    To find out more information about this exciting new project, click here

  • Thu
    18
    Jan
    2018
    Fri
    19
    Jan
    2018
    Derby, UK

    The VASCERN Paediatric and Primary Lymphoedema Working Group (PPL-WG) has organised a two day face-to-face meeting in Derby, U.K. that will take place from January 18th-19th, 2018.

    On the first day, Prof Vaughan Keeley will give participants the chance to visit the Primary and Paediatric Lymphoedema Clinic at Royal Derby Hospital (Derby Teaching Hospitals NHS Foundation Trust). They will meet the clinic's multidisciplinary team as well as attend the Derby Lymphoedema Service Consultants Meeting in the afternoon. This will be a good opportunity for the PPL-WG to share best practices in patient care and to network.

    The Outcome Measures for Treatment Meeting will be held on the second day, January 19th, 2018, where participants will discuss possible outcome measures for PPL in adults and children (e.g. limb volume measurements, cellulitis index, Quality of Life), the proposed frequency of these measurements, and other important considerations.

    Prof Vaughan Keeley, Dr Sarah Thomis, Dr Nele DeVoodgt, Prof Isabelle Quere, Dr Ruth England, and Katie Riches will all be in attendance.

    Consult the Agenda for Day 1 (January 18th, 2018): PPL WG Clinic Visit Agenda

    Consult the Agenda for Day 2 (January 19th, 2018):  PPL WG Outcome Measures Meeting Agenda

     

  • Tue
    16
    Jan
    2018
    17:00PM-18:00PM (CET)Videoconference call - Webex
  • Mon
    15
    Jan
    2018
    17:30 PM - 18:30 PM (CET)Videoconference call - Webex
  • Wed
    10
    Jan
    2018
    17:00 PM-18:00PM (CET)Videoconference call - Webex
  • Tue
    09
    Jan
    2018

    The ERN Call for Specific Grant Agreement (SGA) for the 2nd year of ERN operation (March 2018-February 2019), under the ERN 5 years Framework Partnership Agreement, has been launched on November, 22nd. The deadline to answer is on January, 9th, 2018.

    VASCERN has signed a 5 years Framework Partnership Agreement (FPA) with the European Commission (2017-2022), therefore is eligible for this European Union funding for ERNs, and was invited to answer this call for a second year SGA.

    We are currently working on our proposal for our 2nd year Action Plan and budget to answer this call.

    Support for ERNs Coordination & Operation is provided by the European Union 3rd Health Programme.

    The European Union is co-funding 60% of the total budget. The maximum amount of EU contribution is 200 000 euros by ERN.

    More information 

    Database of EU 3rd Health Programme co-funded projects

    Database: info on VASCERN Framework Partnership Agreement 

    Database: info on VASCERN Specific Grant Agreement (March 2017-February 2018)

     

  • Tue
    09
    Jan
    2018
    10:00AM-11:00AM (CET)Videoconference call - Webex
  • Mon
    08
    Jan
    2018
    19:00PM - 20:00PM (CET)Videoconference call - Webex
  • Mon
    18
    Dec
    2017
    EURORDIS headquarters, Paris, France

    EURORDIS organises a ePAG face to face meeting in Paris. Paolo Federici, chair of our VASCERN ePAG group and ePAG representative for HHT will be there, together with Juergen Grunert, patient co-chair for the Medium Sized Arteries WG (vascular Ehlers Danlos), Christina Grabowski (ePAG representative for HHT) and Lise Murphy (ePAG representative for Heritable Thoracic Aortic Diseases).

  • Mon
    18
    Dec
    2017
    5.30 PM (GMT +1)Videoconference call - Webex
  • Wed
    13
    Dec
    2017
    5 PM (GMT +1)Videoconference call - Webex
  • Mon
    11
    Dec
    2017
    7 PM (GMT+1)Videoconference call - Webex
  • Sat
    09
    Dec
    2017
    France

    All information available here 

  • Fri
    08
    Dec
    2017
    10.30 AM (GMT+1)Videoconference call - Webex

    The VASCERN Council meets every 4 months, or more depending on needs. This is the 3rd VASCERN Council meeting, following Vilnius (March) and virtual meeting last July.The Council is chaired by the Coordinator, Members are the Chairs of our Working Groups.

  • Thu
    07
    Dec
    2017
    Fri
    08
    Dec
    2017
    Rome, Italy

    RD-ACTION and DG Sante organise a workshop on "How can ERNs generate, appraise and use clinical practice guidelines, to enhance the impact and deployment of consensus guidelines in national health systems?"

     

  • Thu
    07
    Dec
    2017

    Publication of the call of December 7th!

    JTC 2018: "Transnational research projects on hypothesis-driven use of multi-omic integrated approaches for discovery of disease causes and/or functional validation in the context of rare diseases"

    More information here

  • Tue
    05
    Dec
    2017
    10 AM (GMT +1) Videoconference call - Webex
  • Tue
    05
    Dec
    2017
  • Tue
    28
    Nov
    2017
    6 PM (GMT+1)Videoconference call - Webex

    Following the Paris face to face meeting during the 1st annual seminar, the VASCERN Registry WG meeting #4 will take place place virtually in November.

    The VASCERN Registry WG will discuss:

    • The EU common minimal dataset for Rare disease registration
    • The FAIR principle, which was presented to all by Dr. Marco ROOS during our 1st Annual Seminar
  • Mon
    27
    Nov
    2017
    5 PM (GMT +1)Videoconference call - Webex

    The VASCERN HTAD-WG (Heritable Thoracic Aortic Diseases) monthly virtual meeting takes place every 4th Monday of every month at 5 PM (GMT +1).

    The HTAD-WG will discuss:

    • Patient pathway
    • Clinical guidelines
    • Pills of Knowledge
    • Registry
    • Clinical case
  • Mon
    20
    Nov
    2017
    5.30 PM (GMT +1)Videoconference call - Webex

    The VASCERN PPL-WG (Pediatric and Primary Lymphedema) monthly virtual meeting takes place every 3rd Monday of every month at 5.30 PM (GMT +1).

    The PPL-WG will discuss:

    • Patient pathways
    • Clinical guidelines
    • Clinical case
    • Clinical guidelines
    • Registry
  • Thu
    16
    Nov
    2017
    Videoconference call - Webex

    Ahead of the Clinical Patient Management System (CPMS) launch, the European Commission organises a virtual meeting with the ERN Coordinators

  • Mon
    13
    Nov
    2017
    7 PM (GMT+1)Videoconference call - Webex

    The VASCERN VASCA-WG (Vascular Anomalies) monthly virtual meeting takes place every 2nd Monday of every month at 7 PM (GMT +1).

    The VASCA-WG will discuss, among others:

    • Patient pathway
    • Registry
    • Clinical trial
    • Clinical case
  • Wed
    08
    Nov
    2017
    5 PM (GMT +1)Videoconference call - Webex

    The VASCERN MSA-WG monthly virtual meeting takes now place every 2nd Wednesday of every month at 5 PM (GMT +1).

    The VASCERN MSA-WG will discuss:

    • Patient pathways
    • Patient passports
    • Clinical trial
    • Registry project
    • Clinical case

     

  • Tue
    07
    Nov
    2017
    10 AM (GMT +1) Videoconference call

    VASCERN Patient Group (ePAG - European Patient Advocacy Group) virtual monthly meeting takes place every 1st Tuesday of every month at 10 AM (GMT +1).

  • Tue
    07
    Nov
    2017
    5 PM (GMT+1)Videoconference call - Webex

    VASCERN eHealth WG monthly virtual meeting takes place every 1st Tuesday of every month at 5 PM (GMT+1).

    The eHealth & Training / Education WG works on:

    • VASCERN-APP: A free Mobile Application for IOS and Android, which will enable patients & doctors to find and reach out easily all VASCERN Centers of expertise and Patient Organisations
    • Pills of Knowledge: to develop education material available in several formats, including Videos (eLearning tools)
    • Availability of conferences & videos on YouTube
  • Fri
    03
    Nov
    2017
    8 AM (GMT+1) Videoconference call - Webex

    The HHT-WG monthly virtual meeting takes place every 1st Friday of the month at 8 AM (GMT+1).

    The HHT-WG will discuss patient pathways & complex clinical cases, among others!

  • Wed
    25
    Oct
    2017
    6.30 PM (Central European Summer Time)Videoconference call
  • Mon
    23
    Oct
    2017
    5 PM (Central European Summer Time)Videoconference call
  • Tue
    17
    Oct
    2017
    Sat
    21
    Oct
    2017
    ORLANDO, FLORIDA

    https://www.ashg.org/2017meeting/

  • Mon
    16
    Oct
    2017
    5.30 PM (Central European Summer Time)Videoconference call
  • Sat
    14
    Oct
    2017
    Paris, France

    During our 1st VASCERN Annual Seminar, which took place in Paris on October 13-14, 2017, our 5 Rare Disease Working Groups have conducted parallel face to face 3.5 hours work sessions in the morning on the 14th.

    These RDWG face to face meetings have been very productive and all the 5 RDWG have made a lot of progresses in the implementation of our action plan.

     

  • Sat
    14
    Oct
    2017
    Paris, France

    During our 1st VASCERN Annual Seminar, which took place in Paris on October 13-14, 2017, our Transversal Working Groups have conducted parallel face to face 2 hours work sessions in the afternoon on the 14th.

    The eHealth & Training/Education WG, as well as the Patient Registy WG have met.

    These face to face meetings have been very productive and both WGs have made a lot of progresses in the implementation of our action plan.

  • Fri
    13
    Oct
    2017
    Sat
    14
    Oct
    2017
    Paris, France

    he VASCERN 1st annual seminar will take place in Paris on October 13-14th! This event will gather 80 participants, including all our Members for the first time!

      @VASCERN 

    Follow & tweet with us using #VASCERNdays2017

    All our 31 Healthcare Providers Members will be represented by 1 or 2 representatives. 12 Patient Organisations, Members of our Patient Group (ePAG), will be represented as well.

    Besides our Members, several VASCERN stakeholders (including the European Commission (ERN team, ERN IT team), ERN Board of Member States French representative, EURORDIS, FAIR Database, the European Joint Programme on Rare Diseases Research, ORPHANET, RD-Action) will be here.

    On October 13th, it will be the first face-to-face gathering of all VASCERN Members since the official launch in Vilnius. This will be the opportunity to discuss:

    • The structure and the functionning of the network since March, 2017;
    • The state of play with regard to the implementation of our 1st year action plan (March 2017-February 2018);
    • The patient involvement within VASCERN, in cooperation with EURORDIS;
    • The achievements, challenges and opportunities for ERNs;
    • The VASCERN Terms of Reference during the official VASCERN Board meeting.

    On October 14th, the five VASCERN Rare Disease Working Groups will held parallel working sessions in the morning.

    In the afternoon, the transversal WGs on eHealth-Training & Education and on Patient Registry will gather.

    Programme available here

    Stay tuned to get the latest news about our 1st Annual Seminar!

  • Tue
    10
    Oct
    2017
    Wed
    11
    Oct
    2017
  • Mon
    09
    Oct
    2017
    7 PM (Central European Summer Time)Videoconference call
  • Fri
    06
    Oct
    2017
    8 AM (European time) Videoconference call
  • Tue
    03
    Oct
    2017
    10:00 am (Central European Summer Time)Videoconference call
  • Tue
    03
    Oct
    2017
    5.00pm (Central European Summer Time)Videoconference call
  • Thu
    28
    Sep
    2017
    Fri
    29
    Sep
    2017
  • Wed
    27
    Sep
    2017
    6.30 PM (Central European Summer Time)Videoconference call
  • Mon
    25
    Sep
    2017
    Fri
    29
    Sep
    2017
    Barcelona, Spain

    Every 2 years, ISL Conference welcomes 1.000 doctors and therapy professionals from all over the world, to benefit from new research and innovate solutions to the many issues faced by health practitioners who treat people with lymphatic dysfunction.
    New deadline for abstract submission : 31st March 2017

    More information and registration here

  • Mon
    25
    Sep
    2017
    Videoconference call
  • Mon
    25
    Sep
    2017
    5.00pm (Central European Summer Time)Videoconference call
  • Sun
    24
    Sep
    2017
    Tue
    26
    Sep
    2017
    Uppsala, Sweden

    http://www.nsva.no/

  • Fri
    22
    Sep
    2017
    Sat
    23
    Sep
    2017
    Lyon, France

    The European Society of Vascular Surgery organises its 31th annual meeting in Lyon on September, 22-23rd 2017.

    All information here

  • Wed
    20
    Sep
    2017
    Antwerp, Belgium

    The Aortic Aneurysm Symposium is organised by our HCP Member Prof. Bart Loeys, from the University Hospital of Antwerp (Belgium), in cooperation with Prof. Jolien Roos-Hesselink from the Erasmus Medical Center (Rotterdam, The Netherlands). Several of our HCP Members from HTAD (Heritable Thoracic Aortic Diseases) will make presentations: Prof Julie De Backer (Ghent University Hospital), Prof Yskert von Kodolitsh (University Medical Center Hamburg-Eppendorf)

    More information:

    FlyerAntwerpenmeeting

  • Tue
    19
    Sep
    2017
    Milan, Italy

    The Aortic Dissection Awareness Day in Milan is organised by our Member Dr Alessandro Pini. VASCERN will be presented! All information on the programme here

    Info on the Aortic Dissection Awareness Day

  • Mon
    18
    Sep
    2017
    Fri
    22
    Sep
    2017
    Rome, Italy

    VASCERN will be represented at this international summer school.

    More info here

  • Mon
    18
    Sep
    2017
    5.30 PM (Central European Summer Time)Videoconference call
  • Wed
    13
    Sep
    2017
    Sun
    17
    Sep
    2017
    Geneva, Switzerland

    http://eadvgeneva2017.org/

  • Tue
    12
    Sep
    2017
    10:00 am (Central European Summer Time)Videoconference call
  • Sun
    10
    Sep
    2017
    Wed
    13
    Sep
    2017
    Buenos Aires, Argentina

    International Symposium of Vascular Anomalies.

  • Mon
    28
    Aug
    2017
    12h-13h Barcelona, Spain

    In the framework of the European Society of Cardiology Congress in Barcelona, the VASCERN HTAD-WG will have its monthly WG meeting in person.

  • Sat
    26
    Aug
    2017
    Wed
    30
    Aug
    2017
    Barcelona, Spain

    More info here

  • Mon
    21
    Aug
    2017
    Virtual meeting - Videoconference call

    Monthly meeting of the VASCERN Pediatric and Primary Lymphedema WG.

  • Wed
    26
    Jul
    2017
    Virtual meeting - Videoconference call
  • Tue
    25
    Jul
    2017
  • Mon
    24
    Jul
    2017
    Virtual meeting - Videoconference call
  • Mon
    17
    Jul
    2017
    Virtual meeting - Videoconference call
  • Thu
    13
    Jul
    2017
    Virtual meeting - Videoconference call
  • Tue
    11
    Jul
    2017
    Virtual meeting - Videoconference call
  • Thu
    06
    Jul
    2017
    Sun
    09
    Jul
    2017
  • Tue
    04
    Jul
    2017
    Videoconference call
  • Thu
    29
    Jun
    2017
    Sat
    01
    Jul
    2017
    Prague, Czech Republic

    In Prague, over two days, 14 leading experts will review recent advances across the spectrum of cardiology. Interact with colleagues, exchange information and ideas, and get updated – helping you to provide the best care for your patients!

    Programme: here

    All information and registration here

     

  • Thu
    29
    Jun
    2017
    Fri
    30
    Jun
    2017
    London, UK

    All information and registration here

  • Wed
    28
    Jun
    2017
    Virtual meeting - Videoconference call

    VASCERN MSA-WG Monthly "virtual" meeting takes place every 4th Monday of the month at 5.30pm (GMT+1). The MSA-WG (Medium Sized Arteries - Vascular Ehlers Danlos) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.

  • Wed
    28
    Jun
    2017
    10.30am (GMT+1)Virtual meeting - Videoconference call
  • Mon
    26
    Jun
    2017
    Virtual meeting - Videoconference call

    VASCERN HTAD-WG Monthly "virtual" meeting takes place every 4th Monday of the month at 5pm (GMT+1). The HTAD-WG (Heritable Thoratic Aortic Diseases) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.

  • Mon
    26
    Jun
    2017
    Virtual meeting - Videoconference call

    The next VASCERN PPL-WG Monthly "virtual" meeting will takes place on Monday 26th June, at 5pm (GMT+1). The PPL-WG (Pediatric and Primary Lymphedema) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.

  • Tue
    20
    Jun
    2017
    Wed
    21
    Jun
    2017
    Brussels, Belgium

    On June 20th & 21th, there will be a Joint meeting of the ERN Board of Member States (BoMS) and the ERN Coordinator's Group (ECG). Issues such as: call for new ERN members joining existing networks, affiliated partners, monitoring of ERNs and relationships between ERNs and Industry will be tackled.

    There will be a training session on the clinical case management system.

    The ECG (ERN Coordinator's Group) will meet and discuss issues such as Governance, ERN IT system, eHealth call for ERNs, research, health programme, monitoring & assessment of ERNs.

  • Wed
    14
    Jun
    2017
    Virtual meeting - Videoconference call

    The VASCERN Ethics-WG first virtual meeting will take place on June 14th.

  • Mon
    12
    Jun
    2017
    Virtual meeting - Videoconference call

    VASCERN VASCA-WG Monthly "virtual" meeting takes place every 2nd Monday of the month at 7pm (GMT+1). The VASCA-WG (Vascular Anomalies) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.

  • Thu
    08
    Jun
    2017
    Sun
    11
    Jun
    2017
    Dubrovnik, Croatia

    Abstract submission here until February 28th

    This International event will gather world’s leading HHT experts in both basic research as well as clinical practice, including our VASCern HHT-WG Chairs and Members.

    Hans Jurgen-Mager, MD, PhD, HCP Representative and Member of the VASCern HHT-WG is also Co-Chair of the Cure-HHT Organising Committee for this international meeting.

    All information and registration available here

  • Thu
    08
    Jun
    2017
    Dubrovnik, Croatia

    In the framework of the Cure HTT 12th International Scientific Conference held in Dubrovnik, Croatia on June 8-11th, our VASCERN HHT-WG Members will have a first VASCERN HHT-WG face-to-face meeting.

  • Tue
    06
    Jun
    2017
    Virtual meeting - Videoconference call

    VASCERN ePAG (Patient Group) representatives are meeting every first Tuesday of the month at 10am (GMT+1) in order to work together, share views and be involved in all VASCERN actions.

  • Tue
    06
    Jun
    2017
    Virtual meeting - Videoconference call

    VASCERN eHealth-WG monthly "virtual" meeting takes place every first Tuesday of the month at 5.30pm (GMT+1). The eHealth-WG works on all the transversal eHealth topics. The WG is especially in charge of the development of the VASCERN Mobile Application, which will facilitate cross-border healthcare and pathways throughout Europe in rare vascular diseases.

  • Thu
    01
    Jun
    2017
    Fri
    02
    Jun
    2017
    Newcastle upon Tyne, UK

    VASCERN will be represented at this workshop.

    "ERNs need to be able to demonstrate their impact across a broad range of fields and activities, which requires carefully-selected indicators and at the same time a monitoring system including Key Performance Indicators should be set up to follow up the activity and caseload of the ERNs."

  • Wed
    31
    May
    2017
    Paris, France

    This workshop is organised by the French Ministry of Research.

  • Fri
    26
    May
    2017
    Sat
    27
    May
    2017
    Stuttgart, Germany

    More information and registration here

  • Mon
    22
    May
    2017
    Videoconference call
  • Fri
    19
    May
    2017
    Sat
    20
    May
    2017
    Budapest, Hungary

    Save the date! All information about the meeting and the patient fellowships are available here

  • Tue
    16
    May
    2017
    Thu
    31
    Aug
    2017

    Call identifier: ERC-2017-AdG

    ERC Advanced Grant Principal Investigators are expected to be active researchers and to have a track record of significant research achievements in the last 10 years which must be presented in the application. There is little prospect of an application succeeding in the absence of such a record, which identifies investigators as exceptional leaders in terms of originality and significance of their research contributions.

    More information in the ERC Work Programme 2017 (pp. 25-28 on AdG)

  • Tue
    16
    May
    2017
  • Wed
    10
    May
    2017
  • Tue
    09
    May
    2017
    Videoconference call
  • Fri
    05
    May
    2017
    Videoconference call

    Meeting organised by EURORDIS with the Patient Group (ePAG) on the development of the ePAG and EURORDIS support

  • Thu
    04
    May
    2017
  • Tue
    02
    May
    2017
    Videoconference call

    The eHealth WG, Chaired by Dr Alessandro Pini, Representative of our Member Centro Malattie Rare  – Marfan Clinic, Milan, Italy, will have its first monthly virtual meeting on May, 2nd. The agenda includes the development of our VASCERN Mobile Application for cross-border healthcare. This Mobile Application (for IOS and Android Smartphone) will enable patients and professionals to easily find all necessary contact information about the expertise centers in rare vascular diseases.

  • Wed
    26
    Apr
    2017
    Thu
    27
    Apr
    2017
  • Tue
    11
    Apr
    2017

    Topic Identification:  SC1-HCO-07-2017

    Stay tuned: here

  • Tue
    11
    Apr
    2017

    Topic identifier: SC1-HCO-03-2017
    Types of action: ERA-NET-Cofund ERA-NET Cofund

    This call should aim at implementing a key area of the PerMed Strategic Research Agenda and be complementary with other funding programmes and activities at European and international level. Proposers are encouraged to include other joint activities including additional joint calls without EU co-funding. This work should be informed by the output of the coordination and support action envisaged in topic SC1-HCO-05-2016 - Coordinating personalised medicine research, without duplicating any of its work.

    The proposed ERA-NET should demonstrate the expected impact on national and transnational programmes as well as the leverage effect on European research and competitiveness, and should plan the development of key indicators for supporting this. Participation of international partners is highly encouraged.

    The Commission considers that a proposal requesting a contribution from the EU of EUR 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

    More information here

  • Tue
    11
    Apr
    2017

    Topic identifier: SC1-PM-03-2017
    Types of action: RIA Research and Innovation action

    Deadline: 11 April 2017

    The aim of this research should be to apply genomics and/or other –omics and/or other high-throughput approaches for the molecular characterisation of rare diseases in view of developing molecular diagnoses for a large number of undiagnosed rare diseases. Undiagnosed rare diseases may range from a group of unnamed disorders with common characteristics to a phenotypically well described disease or group of diseases with an unknown molecular basis. Genetic variability due to geographical distribution and/or different ethnicity should be taken into account as well as genotype-phenotype correlation whenever applicable. In addition, age, sex and gender aspects should be included where appropriate. This large-scale proposal should promote common standards and terminologies for rare disease classification and support appropriate bioinformatics tools and incentives to facilitate data sharing. Existing resources should be used for depositing data generated by this proposal. Molecular and/or functional characterisation may be part of the proposal to confirm diagnosis. The proposal should enable and foster scientific exchange between stakeholders from countries and regions with different practices and strategies of rare disease diagnostics.

    The selected proposal shall contribute to the objectives of, and follow the guidelines and policies of the International Rare Diseases Research Consortium IRDiRC (www.irdirc.org).

    The Commission considers that requesting a contribution from the EU of around EUR 15 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of a proposal requesting other amounts.

    More information here

  • Tue
    11
    Apr
    2017

    Topic identifier: SC1-HCO-08-2017
    Types of action: CSA Coordination and support action

    Any type of activities that can help less performing countries and regions to build capacities and exploit opportunities to eventually increase their participation in EU funded collaborative projects can be supported.

    The proposals will propose concrete measures for tackling structural barriers to health research and innovation, including those related to capacity, skills, policy, regulatory environment, and economic and socio-cultural factors including gender equality issues and gender dimension in research content.

    More information and call documents here

  • Tue
    11
    Apr
    2017

    Topic identifier: SC1-PM-08-2017
    Types of action: RIA Research and Innovation action

    Deadline: April 11th 2017

    Support will be provided to clinical trials on substances where orphan designation has been given by the European Commission, where the proposed clinical trial design takes into account recommendations from protocol assistance given by the European Medicines Agency, and where a clear patient recruitment strategy is presented. Clinical trials may focus on a range of interventions with an orphan designation, from small molecule to gene or cell therapy, may include novel interventions and/or repurposing of existing and known interventions. The intervention must have been granted the EU orphan designation at the latest on the date of the full proposal call closure. A concise feasibility assessment justified by available published and preliminary preclinical or clinical results and supporting data shall also be provided. Appropriate plans to engage with patient organisations, Member States health authorities and considerations of efficacy/potential clinical benefit as well as early indication on health economics should be integrated in the application. In addition to the clinical trial, proposals may also include limited elements of late stage preclinical research and/or experimental evaluation of potential risks which must be complementary/contribute to the clinical trial(s) carried out within the proposal. The centre of gravity must clearly be the clinical trial(s). The participation of SMEs is encouraged.

    More information and call documents here

  • Tue
    11
    Apr
    2017

    Topic identifier: SC1-PM-02-2017
    Types of action: RIA Research and Innovation action

    Deadline: April 11th 2017

    Proposals should deliver novel concepts for disease-mechanism based patient stratification to address the needs for stratified or personalised therapeutic interventions. The proposals should integrate multidimensional and longitudinal data and harness the power of -omics, including pharmacogenomics, systems biomedicine approaches, network analysis and of computational modelling. The new concepts of stratification should be validated in pre-clinical and clinical studies taking into account sex and gender differences. Applicants are encouraged to actively involve patient associations. The proposals should consider regulatory aspects of clinical practice and commercialisation opportunities. Proposals should focus on complex diseases having high prevalence and high economic impact.

    The Commission considers that proposals requesting a contribution from the EU of between EUR 4 and 6 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

    More information and call documents: here

  • Tue
    11
    Apr
    2017

    Topic identifier: SC1-PM-10-2017
    Types of action: RIA Research and Innovation action

    Deadline: April 11th 2017

    Proposals should compare the use of currently available preventative or therapeutic (pharmacological as well as non-pharmacological) healthcare interventions in adults[1]. While there is no restriction on the diseases or interventions to be the focus of proposals, preference will be given to proposals focusing on interventions with high public health relevance and socio-economic impact, i.e. interventions addressing conditions that are particularly frequent, may lead to co-morbidities, have a high negative impact on the quality of life of the individual and/or are associated with significant costs or where savings can be achieved. A cost effectiveness analysis must be included. Given the focus on existing interventions, proposals will aim to contribute to improve interventions, take decisions about the discontinuation of interventions that are less effective or less cost-effective than others, and make recommendations on the most effective and cost-effective approaches. A comprehensive array of clinical and safety parameters, as well as health and socio-economic outcomes (e.g. quality of life, patient mortality, morbidity, costs, and performance of the health systems) for chosen populations should be assessed. Agreed core outcome sets (COS) should be used as endpoints in conditions where they already exist, in other cases efforts should be made to agree on such COS. Randomised controlled trials, pragmatic trials, observational studies, large scale databases and meta-analyses may be considered for this topic. Where relevant the study population should address gender as well as socio-economic differentials in health and/or any other factors that affect health equity.

    More information and call documents here

  • Tue
    11
    Apr
    2017

    Topic identifier: SC1-PM-20-2017
    Types of action: RIA Research and Innovation action

    Deadline: April 11th 2017

    More information and call documents here

  • Fri
    07
    Apr
    2017
    Dublin, Ireland

    Organised by Rare Diseases Ireland. Info and registration here

  • Tue
    04
    Apr
    2017
    Videoconference call
  • Fri
    31
    Mar
    2017

    If you follow a cohort of patients with FMD, and are willing to contribute to the European FMD registry and join a network of specialists interested by the clinical and basic aspects of the disease, please contact us (FMD-saintluc@uclouvain.be).

    Read the call here

  • Tue
    21
    Mar
    2017
    Wed
    22
    Mar
    2017
    Madrid, Spain

    The European Commission organises a Workshop on Rare Diseases Registries in Madrid (March 21-22nd), on the dissemination of the 2008-2015 Health Programme results. This is organized in cooperation with the Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III - Spanish Ministry of Economy, Industry and Competitiveness. The event will disseminate results of the EU Health Programme co-funded conducted projects and Joint Actions on Registries.

    The future European platform on Rare Diseases Registration, as well as Registries through the European Reference Networks will be tackled.

    Registration until March 20th here

    Agenda here

  • Tue
    21
    Mar
    2017

    Aim: increase knowledge on rare diseases and develop clinical research

    Eligibility: only applicants members of approved ERNs are eligible to be co-funded.

    Scope: from at least 3 countries
    Description: The activities to be carried out concern the creation of 3-4 new registries on rare diseases. These registries should constitute key instruments to increase knowledge on rare diseases and develop clinical research. Collaborative efforts to establish data collection and maintain them will be considered, provided that these resources are open and accessible. Registries should be built with the support and according to the standards set up by the European Platform on rare diseases registration and provide all necessary data to the Platform (taking the relevant data protection rules into account).

    Call text: here

     

    Budget: EUR 1.200.000 (indicative budgetary ceiling per grant to be awarded in 2017 is EUR 400.000, for 3 to 4 registries)

    Deadline: March, 21st

    All information: here

  • Mon
    20
    Mar
    2017
    Valletta, Malta

    This high-level workshop is organised by the Maltese Presidency of the EU Council of the European Union at the Grand Master’s Palace , in parallel to the informal meeting of EU Ministers of Health. The Maltese Presidency has established Rare Diseases as one of its core priorities.

    European Reference Networks will be represented to this meeting.

    "The aim is to discuss the possibilities for structured cooperation in rare diseases research, tools, and healthcare at the EU level and ways of adapting already existing programmes by scaling them up and integrating them under the same umbrella, creating a sustainable ecosystem of knowledge generation."

  • Tue
    14
    Mar
    2017
    Teleconference call
  • Thu
    09
    Mar
    2017
    Fri
    10
    Mar
    2017
    Vilnius, Lithuania

    The European Commission (DG Health) organises the 3rd European Reference Networks Conference on March, 9-10th in Vilnius, Lithuania.

    The ERN Conference will focus on the presentation of the newly 24 approved European Reference Networks, and will be the official launch and start of ERNs (see here the list of approved ERNs).

    There will be an ERN awarding ceremony, introduced by the EU Commissioner for Health, Vytenis Andriukaitis, who will also open the ERN Conference.

    The conference on 9th will tackle topics such as:

    • Coordination, management & governance of ERNs;
    • ERN IT platform as core element for eHealth, telemedicine, sharing of expertise in complex clinical cases;
    • EU policies and support to ENRs (research, registry platform, rare diseases policy…);
    • ERN and national healthcare systems;
    • The way forward with perspectives of Healthcare providers, patient representatives, ERN Coordinators, Member States.

     

    On March 10th, the 24 new ERNs will officially start working with a kick-off meeting!

    VASCERN will hold its first face-to-face Council kick-off meeting on 10th, with a part of VASCERN HCP and Patient representatives (Chairs and co-chairs of VASCERN Working Groups).

    Agenda here

    All information and live webstream on March, 9th here

  • Mon
    06
    Mar
    2017

    Watch the video for the World Lymphedema Day! 

     

  • Sun
    05
    Mar
    2017
    Wed
    08
    Mar
    2017
    Boston, Massachusetts, USA

    All information and registration here

  • Tue
    28
    Feb
    2017

    rdd-logo

    How to get involved and support Rare Diseases Day 2017: here

    All information available here

  • Tue
    28
    Feb
    2017
    University Hospital of Leuven, Belgium

    The European Commission organises a ERN journalist study visit at the University Hospital of Leuven. Prof Guillaume Jondeau, VASCERN Network Coordinator and Dr Sarah Thomis, Univ. Hospital of Leuven HCP Representative, Member of the Pediatric and Primary Lymphedema WG (PPL-WG) will present VASCERN, together with a PPL Patient representative (Be-Lymph).

  • Mon
    27
    Feb
    2017
    Teleconference call
  • Thu
    23
    Feb
    2017

    Being nearly at the half-way point of the 3rd Health Programme which runs from 2014 to 2020, the Commission would like to evaluate whether it is meeting its objectives and whether there is room for improvement.

    Answer here to the EU Consultation on the 3rd European Health Programme ! It is open to any interested parties in order to gather views and opinions on:

    • The objectives and priorities of the 3HP, and the extent to which these are appropriate and in line with health needs in the EU
    • The way the 3HP is implemented, and the extent to which this is effective and efficient
    • The overall added value and usefulness of the 3HP

    More info here

  • Wed
    22
    Feb
    2017
    Thu
    23
    Feb
    2017
  • Sat
    18
    Feb
    2017
    Antwerp, Belgium

    A special event on Marfan Syndrome and Loeys-Dietz is organised by the University of Antwerp and Bindweefsel.be. More information here

  • Tue
    14
    Feb
    2017
    Teleconference call

    VASCERN Vascular Anomalies (VASCA) Working Group Members first meeting as an ERN group

  • Fri
    10
    Feb
    2017
    Geneva, Switzerland

    "The event is the first of its kind to be organised in Geneva and will gather international experts in the fields of public health, human rights, epidemiology, scientific research and patient advocacy to discuss why and how rare diseases should be included in the global health agenda."

    All information and registration here

  • Thu
    09
    Feb
    2017

    Call identifier: ERC-2017-CoG

    Deadline: February, 9th 2017

    ERC Consolidator Grants are designed to support excellent Principal Investigators at the career stage at which they may still be consolidating their own independent research team or programme. Applicant Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal. Principal Investigator shall have been awarded his or her first PhD > 7 and ≤ 12 years prior to 1 January 2017. 

    More information in the ERC 2017 Work Programme (pp. 23-24 on CoG)

  • Wed
    08
    Feb
    2017
    Thu
    09
    Feb
    2017
    Paris, France

    The third conference of the International Rare Diseases Research Consortium (IRDiRC) will take place February 8-9, 2017 in Paris, France.

    All information here Programme here Registration here 

  • Wed
    01
    Feb
    2017

    The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach. Projects shall involve a group of rare diseases or a single rare disease following the European definition i.e. a disease affecting not more than five in 10.000 persons in the European Community, EC associated states and Canada.

    The specific objective of this call is to promote research projects focusing on the pre-clinical development of therapeutic approaches in suitable existing animal or cell models.

    Date of publication: December 5th 

    Deadline for proposal pre-registration: February 1, 2017

    Deadline for proposal submission: June 2nd, 2017

    More information here

    Call document: here 

    Call forms: here

    Guidelines: here

     

  • Tue
    31
    Jan
    2017

    The European Commission (DG Health) has launched a new call for proposals for a pilot project in the area of Rare Diseases. This will be founded by the European 3rd Health Programme.

    PP-2-1-2016 - Pilot project — Establishing a Registry of Rare Congenital Malformations (as part of the Rare Diseases Registry), drawing on the structure, organization and experience of the Registry of Congenital Malformations

    • The key objective of this pilot project is to set up a registry of rare congenital malformations as a part of rare diseases national registers. The project should be implemented at a national level.
    • The secondary aim of the project is to provide an example of how to extend an existing birth defects registration and surveillance system to a rare diseases registration system.
    • The birth defects registration system has already been set up in several MSs as part of the EUROCAT surveillance network. The pilot project provides a model for exploring whether a birth defects registry can be extended to form a rare diseases registry.
    • The pilot project should contribute to the development of an EU Platform on Rare Diseases Registration to provide a common access point to data collections on rare diseases across Europe and to be compatible with platform tools.

    Opening: October 27th 2016
    Deadline: January 31st 2017
    Call document: here 
    More information and link for submission here

     

  • Wed
    25
    Jan
    2017
    Sat
    28
    Jan
    2017
    Turin, Italy

    Prof Guillaume Jondeau will present VASCERN at the 20th Turin Meeting on Rare Diseases (ERN Roundtable). The European Commission as well as 5 other ERNs will be there and make presentations!

  • Sun
    15
    Jan
    2017

    The objective of the consultation is to collect information from a wide audience on different aspects of Horizon 2020 implementation. The results of this consultation will feed into the report on the interim evaluation of Horizon 2020, will help the European Commission to improve the implementation of Horizon 2020 and will set the scene for the future discussions on the next EU research and innovation funding post-2020.

    Answer to the consultation here 

    Deadline: January 15th 2017

  • Tue
    10
    Jan
    2017

    All information on the calls for Innovative Training Networks available here

    Deadline: January 10th 2017

  • Thu
    15
    Dec
    2016
    Sat
    17
    Dec
    2016
    Milano, Italy

    The main philosophy of the meeting will be unchanged and our mission will be to offer to the participants an update focused mostly on the practical aspect of vascular surgery through a dynamic format based on rapid paced presentations.

    All information are available here

  • Thu
    15
    Dec
    2016
    Brussels, Belgium

    The ERN Board of Member States (maximum of 2 representatives from each EU Member States and EEA) and will meet on December 15th to take the decision on the approval of the Networks and HCPs positively assessed by the Independant Assessment Body.

    Read the Rules of Procedures of the Board of MS of the ERNs

    More information on the BoMS here

  • Sat
    10
    Dec
    2016
    Brussels, Belgium

    Programme and contact for registration available here

    Read the recent review paper on Fibromuscular Dysplasia and the European FMD initiative , a collaborative research coordinated by Prof. Alexandre Persu, Cliniques Universitaires St Luc, Brussels

  • Thu
    08
    Dec
    2016
    Brussels, Belgium

    During this meetingn, the European Commission will inform ministers on the European reference networks.

    More information here

  • Wed
    07
    Dec
    2016

    COST is the longest-running European framework supporting trans-national cooperation among researchers, engineers and scholars across Europe.

    You can submit your COST Action proposal at any time throughout the year via the new e-COST online submission tool. The next Collection Date is set for December 7, 2016. 

    There will be a next collection date in September 2017.

    All information on COST Action here

    Call documents and guidelines to submit a proposal here

  • Mon
    05
    Dec
    2016

    Conference Call meeting of the VASCern ePAG representatives, organised in cooperation with EURORDIS.

  • Wed
    30
    Nov
    2016

    The next session will take place 5-9th June 2017 in Barcelona.  The deadline for applications is 30th November 2016.

    Info and registration here

  • Tue
    29
    Nov
    2016
    Wed
    30
    Nov
    2016
    Brussels, Belgium

    The conference will specifically celebrate the 10th anniversary of the UN Convention on the rights of persons with disabilities. Presentations and discussions will focus in an interactive way on the progress which has been made in the EU to promote the rights of persons with disabilities, based on the UN Convention.

    All information here

  • Thu
    24
    Nov
    2016
    Rome, Italy

    The aim of the conference is to disseminate the findings from the RARE-Bestpractices project and offer a forum for discussing with relevant stakeholders how this work could be taken into account in delivering better health decision making and health policies for rare diseases.

    More information and registration here

  • Tue
    15
    Nov
    2016
    Thu
    17
    Nov
    2016
    Brussels, Belgium

    All information and registration here

  • Tue
    08
    Nov
    2016
    Tue
    14
    Mar
    2017

    Topic identifier: SC1-PM-19-2017
    Types of action: PPI Public Procurement of Innovative solutions

    Proposals should address as primary aim public procurement of innovative solutions (PPI) to facilitate the deployment of an eHealth infrastructure taking into consideration the European eHealth Interoperability Framework and EU guidelines adopted by the eHealth Network. The PPI(s), and any accompanying innovation activities in particular by participating procurers themselves to facilitate the uptake of newly developed solutions, should focus on clear target outcomes such as allowing the sharing of health information, the use of semantically interoperable Electronic Health Records (EHRs) for safety alerts, decision support, care pathways or care coordination. The scope of the PPI(s) is to specify, purchase and deploy innovative ICT based solutions which can deliver sustainable, new or improved healthcare services across organisational boundaries while implementing eHealth interoperability standards and/or specifications (e.g. EN13606, HL7, Continua Alliance, IHE...).

    The Commission considers that proposals requesting a contribution from the EU of between EUR 3 and 4 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

    More information and call documents here

  • Tue
    08
    Nov
    2016
    Tue
    14
    Mar
    2017

    Topic identifier: SC1-PM-17-2017
    Types of action: RIA Research and Innovation action

    More information and call documents here

  • Tue
    08
    Nov
    2016
    Wed
    09
    Nov
    2016
    Brussels, Belgium

    The EPF conference “Patient and family empowerment for better patient safety” will explore these issues, including:
    •The ethics of patient involvement in safety: taking responsibility or being burdened with responsibility?
    •Challenges for patient empowerment and involvement in acute care settings
    •Challenges for healthcare professionals: is a fundamental culture change needed?
    •Communication: a risk factor or an opportunity to improve safety?

    All info here

  • Sun
    30
    Oct
    2016
    Thu
    03
    Nov
    2016
    Boston, US

    All information and registration here

  • Fri
    28
    Oct
    2016
    Sun
    30
    Oct
    2016
    Boston, USA

    All information and registration here

  • Wed
    26
    Oct
    2016
    Thu
    27
    Oct
    2016
    Chicago, Illinois, US

    ConferenceSeries and its subsidiaries including iMedPub LLC and Conference Series LLC Organise 3000+ Conferences across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

    All information and registration here

  • Mon
    24
    Oct
    2016
    Brussels, Belgium

    Conference on cross-border healthcare Directive “Towards amplified awareness of EU rights to cross-border care” - European Commission

    The conference aims mainly at:

    • Improving information provision to enable patients to cross-border healthcare;
    • Fostering better coordination between NCPs;
    • Amplifying NCP cooperation with patient organisations, healthcare providers and healthcare insurers for the benefit of patients.

    More information here

  • Thu
    20
    Oct
    2016
    Paris, France

    The French Rare Diseases Foundation (Fondation Maladies Rares) organises a seminar (in French) on Social and Human Sciences (SHS) projects and Rare Diseases. It includes a session on primary lymphoedema and financial inequalities in access to care.

    Draft programme: here

  • Wed
    19
    Oct
    2016
    Thu
    20
    Oct
    2016
    Cap Town, South Africa

    The purpose of this conference is to provide a global forum for all stakeholders within the Rare Diseases field, both locally and abroad, to participate in open discussion, enhance models of best practice and share specialist knowledge around rare diseases and orphan drugs. Incorporating the annual International Conference on Rare Diseases and Orphan Drugs (ICORD) for 2016, RareX has an extended program, to incorporate patients, their families and caregivers as well as support groups and minority groups within the rare disease community.

    All information and registration here

  • Fri
    14
    Oct
    2016
    Brașov, Romania

    This initiative consists of a series of half-day events where national research communities are informed by representatives of the COST Association about the COST Framework’s policies, activities and funding opportunities, with an emphasis on the Open Call for new COST Actions proposals.

    Information and registration here

  • Tue
    11
    Oct
    2016
    Wed
    12
    Oct
    2016
    Paris, France

    MAIN OBJECTIVES

    • To provide an overview of the latest scientific developments and challenges related to the use of ICT in medical research
    • To reflect on the regulatory, sociological, ethical, logistical and methodological framework for using ICT in medical research
    • To assess the state-of-the-art on the subject at an international level
    • To present, during innovation sessions, the products or solutions under development that could be applied in medical research
    • To promote partnerships between academic researchers and R&D scientists from the e-health industry
    • To increase public-private networking to develop long-term collaborations around ICT
    • To create the conditions for the collaborative development of tomorrow’s medical research

    All information and registration here

  • Mon
    10
    Oct
    2016
  • Wed
    28
    Sep
    2016
    Thu
    29
    Sep
    2016
    Brussels, Belgium

    RD-Action, the European initiative supporting the rare disease community and especially the ERN project, organises a 2-days Workshop on "Exchanging data for virtual care within the ERN Framework". The overall aim of this workshop is to generate and agree guidance and good practices for ERNs to collect and share data for care within the framework of ERNs. Potential Coordinators of the ERN project proposals being currently assessed by the European Commission have been invited to attend.

     

  • Tue
    27
    Sep
    2016
    Barcelona, Spain

    "Bringing solutions to young rare disease patients"

    Let's discuss the paediatric regulation

    All information here 

  • Mon
    26
    Sep
    2016
    Fri
    30
    Sep
    2016
    National Centre for Rare Diseases, Rome

    The two events intend to promote the establishment of Findable, Accessible, Interoperable and Reusable (FAIR) Rare Disease (RD) registries in compliance with the IRDiRC and EU Recommendations and to support cooperation among different registry stakeholders and coordination with registries that are developed within National Plans in the EU in the field of rare diseases.

    All information available:  here

  • Mon
    26
    Sep
    2016
    Brussels, Belgium

    The European Reference Network Board of Member States next meeting will take place in Brussels on September, 26th. The Member States representatives should discuss the 24 ERN Project Proposals which were submitted to the European Commission (DG Sante).

  • Thu
    22
    Sep
    2016
    Fri
    23
    Sep
    2016
    Washington Capital Hilton in Washington, DC

    The 4th, and final, GenTAC Thoracic Aortic Disease Summit will be held September 22-23, 2016 at the Washington Capital Hilton in Washington, DC. The previous 3 Thoracic Aortic Disease Summits brought together prominent clinical, translational and basic scientists who presented research on disease etiology, pathogenesis, progression and treatment. This meeting will be held to continue sharing new findings from GenTAC and the research community, to discuss the current advances regarding disease pathogenesis, progression, and treatment and to identify future directions for the field.

    More information here

  • Thu
    22
    Sep
    2016
    Fri
    23
    Sep
    2016
    Paris, France

    This International Conference will cover a vast range of topics, related to how “Engaging stakeholders for responsible Stem Cells research”. Our aim is to create a Task Force for improving the collaboration of  key stakeholders involved in the questions raised by the use of stem cells.

    More information here

  • Wed
    21
    Sep
    2016
    Sat
    24
    Sep
    2016
    Barcelona, Spain

    The 17th Biennial Meeting of the European Society for Immunodeficiencies (ESID 2016) offers unparalleled access to the latest research and analysis in the field of immunodeficiencies.

    More information and registration here

  • Mon
    19
    Sep
    2016

    More information: here and on the Facebook page here

  • Sat
    17
    Sep
    2016
    Waterloo, Belgium

    The Center for Vascular Anomalies (FR / EN)at Cliniques universitaires Saint-Luc in Brussels, Belgium, which takes care of a whole variaty of pathologies within the field of Vascular anomalies, organise its 25 years anniversary event on September, 17th. This HCP is represented in VASCern by Pr. Laurence BOON and Pr. Miikka VIKKULA, and Chair the VASCA-WG.

    More information on this event and registration here

  • Wed
    14
    Sep
    2016
    Sat
    17
    Sep
    2016
    Heidelberg, Germany

    Through the tremendous advances in the technology of mass spectrometry-based proteomics and its applications, the research has expanded to most areas of biology that deal with proteins. This conference will focus on the application of proteomics to cell biology and unraveling disease mechanisms by addressing conceptually novel ways to study long-standing questions in these fields.

    Topics

    • Cell Biology
    • Cell Signaling
    • Omics in Biology
    • Interaction proteomics
    • Chromatin proteomics
    • Genetics and disease

    More information and registration here

  • Mon
    12
    Sep
    2016
    Wed
    14
    Sep
    2016
    Berlin, Germany

    Genomics-2016 welcomes members around the world focused on learning about Genomics & Pharmacogenomics and its advances; this is your best opportunity to reach the largest assemblage of participants from the Genomics and its allied areas.

    More information and registration here

  • Thu
    08
    Sep
    2016
    Fri
    09
    Sep
    2016
    Ågrenska, Gothenburg, Sweden

    As part of the European project INNOVCare, EURORDIS is organising a workshop on “Integrated Care for People Living with Rare Diseases” - 8-9 September, Gothenburg. Focus on: developing a pilot care pathway, using “case management” to link health, social and community services supporting people with a rare disease.
    agenda
    Registration: contact raquel.castro@eurordis.org before July, 15th

  • Sat
    27
    Aug
    2016
    Wed
    31
    Aug
    2016
    Rome, Italy

    The world's largest and most influential cardiovascular congress.

    All information here

  • Tue
    02
    Aug
    2016
    Tue
    05
    Sep
    2017

    The ERC Proof of Concept Grants aim to maximise the value of the excellent research that the ERC funds, by funding further work (i.e. activities which were not scheduled to be funded by the original ERC frontier research grant) to verify the innovation potential of ideas arising from ERC funded projects. Proof of Concept Grants are therefore on offer only to Principal Investigators whose proposals draw substantially on their ERC funded research.

    More information in the ERC Work Programme 2017 (pp. 36-42)

  • Tue
    26
    Jul
    2016
    Tue
    18
    Oct
    2016

    Call identifier: ERC-2017-StG

    ERC Starting Grants are designed to support excellent Principal Investigators at the career stage at which they are starting their own independent research team or programme. Applicant Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal. Principal Investigator shall have been awarded his or her first PhD ≥ 2 and ≤ 7 years prior to 1 January 2017.

    More information in the 2017 ERC Work Programme (see pp. 21-22 for Starting Grants)

     

  • Tue
    12
    Jul
    2016
    Online

    The EURATOM Programme  aims to pursue nuclear research and training activities with an emphasis on continually improving nuclear safety and security, but there is also space for health-related projects under the fields of nuclear medicine, radiation protection and development of medical applications of radiation, including, inter alia, the secure and safe supply and use of radioisotopes.

    All information and registration here

  • Fri
    08
    Jul
    2016
    Brussels

    The InfoDay on H2020 Program for Health, Demographic Change and Wellbeing, will help interested stakeholders to find out information about the upcoming calls, development of a H2020 project proposal, partnerships, etc.

    More info here

  • Thu
    30
    Jun
    2016
    Berlin, Germany
    • Connecting and exchanging each in the worlds fastest growing business
    • Hear and learn best practises how to implement innovation in corporate culture
    • Solving healthcare challenges together
    • Accelerating transforming healthcare in digital times
    • Validate the economics of digital health and how consumer are likely to react to inception
    • Identify business opportunities within emerging markets healthcare system

    All information here

  • Thu
    02
    Jun
    2016
    Fri
    10
    Jun
    2016
    Amsterdam

    eHealth Week 2016 is organised by the Dutch Ministry of Health as part of the Dutch Presidency of the Council of the European Union, the European Commission and HIMSS Europe. This year’s educational programme will focus on three main themes: Empowering People, Trust & Standards and Social Innovation & Transition.

    More information and registration here

  • Wed
    01
    Jun
    2016
    Thu
    02
    Jun
    2016
    Brussels

    The European Commission, DG Research and Innovation, organise a conference on Personalised Medicine. This two days event aim to foster research on Health new technologies, innovation, sustainable health. More information and inscription on the European Commission dedicated page here

  • Thu
    26
    May
    2016
    Sat
    28
    May
    2016
    Edimbourg

    The European Conference on Rare Diseases and Orphan Products is organised by EURORDIS - the association which represents the Voice of Patient Organisations throughout Europe - with the support of the European Commission. It will be an opportunity to meet all European Partners and stakeholders involved in Rare Diseases, thus fostering European cooperations. More info and registration here

  • Wed
    25
    May
    2016
    Brussels

    ERN Coordinators applicants are going to meet in Brussels on May, 25th with the European Commission. During this meeting, the status of ERN applications, progresses and difficulties will be discussed.

  • Wed
    18
    May
    2016
    Fri
    20
    May
    2016
    Tübingen (Germany)

    This congress will address  topics such as : high-throughput methods and data analysis, functional imaging in multiomics approaches, application of PM in clinical decision making and translation of PM into clinical trials in state of the art lectures, hands on workshops and interactive discussion rounds.

    More information here

  • Thu
    12
    May
    2016
    Fri
    13
    May
    2016
    Oslo

    The European Programme for Research and Innovation, Horizon 2020, cofunds research projects in the field of Rare Diseases (call H2020 2016-2017) : New therapies for Rare Diseases and Diagnostic characterisation of rare diseases. The Norvegian Council for Research, together with the French Institute of Oslo organise this event in order to gather Project leaders and potential European partners from the scientific community around research projects in Rare Diseases.

    Programme and registration

     

  • Tue
    03
    May
    2016
    Fri
    06
    May
    2016
    New York

    The International Symposium on Ehlers-Danlos Syndrome will take place in New York between May 3–6, 2016. All information can be found here

    The Vascular Committee includes several of our ERN Members, who are dealing with vascular Ehlers-Danlos Syndrome (vEDS) in the framework of our Medium Size Arteries Diseases Working Group : Pr. Julie De Backer, Dr. Leema Robert, Pr. Xavier Jeunemaître, and further partners.

  • Thu
    07
    Apr
    2016
    Brussels

    The ERN Call for proposal 2016 was released on March, 16th, with a deadline on June, 21st. This first ERN Info Day aims to gather all stakeholders interested and currently drafting ERN proposals to explain the Call as well as to answer all questions.

  • Wed
    06
    Apr
    2016

Comments are closed